Mary DiBiase
Chief Operating Officer bij X4 PHARMACEUTICALS, INC.
Vermogen: 405 535 $ op 31-03-2024
Profiel
Mary DiBiase is currently the Chief Operating Officer at X4 Pharmaceuticals, Inc. She started this position in 2021.
Prior to her current role, she held several positions in the pharmaceutical industry.
From 1995 to 2011, she worked at Biogen, Inc. as a Senior Director-CMC Management.
In 2011, she joined Pfizer Inc. as the Vice President-Product Operations.
From 2013 to 2016, she worked at EPIRUS Biopharmaceuticals, Inc. as the VP-Technical Operations & Program Management.
Dr. DiBiase holds a doctorate degree from the University of Rhode Island and an undergraduate degree from the University of London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC.
0.17% | 11-03-2024 | 291 752 ( 0.17% ) | 405 535 $ | 31-03-2024 |
Actieve functies van Mary DiBiase
| Bedrijven | Functie | Begin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Chief Operating Officer | 08-09-2021 |
Eerdere bekende functies van Mary DiBiase
| Bedrijven | Functie | Einde |
|---|---|---|
| EPIRUS BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-01-2016 |
| PFIZER, INC. | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2011 |
Opleiding van Mary DiBiase
| University of Rhode Island | Doctorate Degree |
| University of London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
